Deal supported by Xplico

Lexicon And Ipsen Enter Into Ex-North America/Japan Licensing And Commercialization Agreement For Telotristat Etiprate

By |November, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Dicerna Announces License Agreement with Tekmira to Advance Dicerna’s PH1 Development Program

By |November, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

LEO Pharma and Japan Tobacco Enter into License Agreement for Novel JAK inhibitor Drug Candidate

By |November, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Bavarian Nordic Enters Licensing and Supply Agreement with Janssen on MVA-BN® Ebola Vaccine

By |October, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Distribution, License & Supply Agreement Announced with Medical Developments International

By |September, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Allergan Acquires LiRIS®Program from TARIS Biomedical®

By |August, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

uniQure Acquires Cardiology Gene Therapy Company InoCard

By |August, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim

By |August, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

Zealand and Boehringer Ingelheim sign second collaboration agreement to advance novel peptide medicines

By |July, 2014|Categories: Deal flow|0 Comments

Deal supported by Xplico

LEO Pharma & KLOX Technologies strike global dermatology deal

By |July, 2014|Categories: Deal flow|0 Comments